A new study has shown that statins, commonly used to treat high cholesterol and blood pressure, could also be effective in treating bowel cancer.
The research, co-funded by Rosetrees and Bowel Research UK, was carried out by a team of researchers, led by Dr Sarah Martin, at Queen Mary University of London. They tested over 1,200 FDA-approved drugs on laboratory-grown colon cells with a specific bowel cancer genetic mutation. Three drugs were found to kill the tumour cells, all of which were statins (Lovostatin, Mevastatin and Simvastatin).
This exciting discovery could provide a new treatment for the thousands of people diagnosed with bowel cancer every year. Click the link for more details of the publication in Frontiers in Oncology.